IT1190675B - 3-chinuclidinil glicolati leganti di recettori ed elementi raggi gamma,metodo di loro preparazione e metodi di visualizzazione e analisi mediante loro impiego - Google Patents

3-chinuclidinil glicolati leganti di recettori ed elementi raggi gamma,metodo di loro preparazione e metodi di visualizzazione e analisi mediante loro impiego

Info

Publication number
IT1190675B
IT1190675B IT19397/82A IT1939782A IT1190675B IT 1190675 B IT1190675 B IT 1190675B IT 19397/82 A IT19397/82 A IT 19397/82A IT 1939782 A IT1939782 A IT 1939782A IT 1190675 B IT1190675 B IT 1190675B
Authority
IT
Italy
Prior art keywords
chinuclidinyl
glycolates
receptors
binders
analysis
Prior art date
Application number
IT19397/82A
Other languages
English (en)
Other versions
IT8219397A0 (it
Inventor
William C Eckelman
Richard C Reba
Warclaus J Rzeszotarski
Raymond E Gibson
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of IT8219397A0 publication Critical patent/IT8219397A0/it
Application granted granted Critical
Publication of IT1190675B publication Critical patent/IT1190675B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT19397/82A 1981-12-31 1982-02-02 3-chinuclidinil glicolati leganti di recettori ed elementi raggi gamma,metodo di loro preparazione e metodi di visualizzazione e analisi mediante loro impiego IT1190675B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/336,340 US4431627A (en) 1980-06-03 1981-12-31 Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; methods of preparation thereof and imaging and assay methods utilizing same

Publications (2)

Publication Number Publication Date
IT8219397A0 IT8219397A0 (it) 1982-02-02
IT1190675B true IT1190675B (it) 1988-02-24

Family

ID=23315645

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19397/82A IT1190675B (it) 1981-12-31 1982-02-02 3-chinuclidinil glicolati leganti di recettori ed elementi raggi gamma,metodo di loro preparazione e metodi di visualizzazione e analisi mediante loro impiego

Country Status (5)

Country Link
US (1) US4431627A (it)
EP (1) EP0097647A4 (it)
JP (1) JPS58502203A (it)
IT (1) IT1190675B (it)
WO (1) WO1983002229A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728600A1 (de) * 1987-08-27 1989-03-09 Hoechst Ag Verfahren zur markierung von substanzen mit technetium oder rhenium
US5262175A (en) * 1989-05-10 1993-11-16 Solanki Kishor K Stabilization of radiopharmaceutical compositions
US5589576A (en) * 1989-08-29 1996-12-31 Amersham International Plc Cores for technetium radiopharmaceuticals
US6001979A (en) 1989-08-29 1999-12-14 Nycomed Amersham Plc Cores for technetium radiopharmaceuticals
CA2034042C (en) * 1990-01-18 1999-08-17 Adrian D. Nunn Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
DE69132735T2 (de) * 1990-09-06 2002-05-29 Pfizer Inc., New York Anti-muscarin bronchodilatoren
GB9621609D0 (en) 1996-10-16 1996-12-04 Howden Packaging Equipment Lim Packaging machine
EP1103284A3 (de) 1999-11-24 2001-09-19 Siemens Building Technologies AG Brandbekämpfungssystem für Autotunnels
CA2433128C (en) * 2000-12-28 2010-05-25 Almirall Prodesfarma Ag Novel quinuclidine derivatives and medicinal compositions containing the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB725228A (en) * 1952-06-19 1955-03-02 Roche Products Ltd Substituted carbamic acid esters and process for the manufacture thereof
US3405134A (en) * 1965-08-17 1968-10-08 Colgate Palmolive Co Quinuclidyl esters of aromatic acids
US3833592A (en) * 1966-05-31 1974-09-03 Little Inc A Tropanyl alpha,alpha-diphenyl-alpha-fluoroacetate esters
SE321933B (it) * 1967-10-05 1970-03-23 Astra Ab
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
US4082756A (en) * 1971-04-16 1978-04-04 Colgate-Palmolive Company Quaternary quinuclidinium carbamates and thiocarbamates
US3910929A (en) * 1972-05-05 1975-10-07 Hercules Inc Polyfunctional quaternary amidoximidinium salts
US4017596A (en) * 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
FR2322867A1 (fr) * 1975-09-08 1977-04-01 Merck Sharp Dohme Cie Chimique Procede de preparation d'esters de 3-quinuclidinol et d'halogenohydrates de ces esters
US4360511A (en) * 1978-11-29 1982-11-23 Medi-Physics, Inc. Amines useful as brain imaging agents
EP0024464B1 (en) * 1979-08-29 1982-05-12 Nihon Medi-Physics Co., Ltd. 2-oxopropionaldehyde bis(thiosemicarbazone)derivatives and their production and use
US4363793A (en) * 1979-08-30 1982-12-14 State University Of New York Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues
WO1981003422A1 (en) * 1980-06-03 1981-12-10 Research Corp Gamma-emitting receptor-binding quinuclidinyl benzilates;methods of preparation thereof and imaging and assay methods utilizing same

Also Published As

Publication number Publication date
WO1983002229A1 (en) 1983-07-07
US4431627A (en) 1984-02-14
EP0097647A4 (en) 1985-11-07
EP0097647A1 (en) 1984-01-11
JPS58502203A (ja) 1983-12-22
IT8219397A0 (it) 1982-02-02

Similar Documents

Publication Publication Date Title
DK516883A (da) Fremgangsmaade og anlaeg til diffraktionstomografi
IT1140242B (it) Oggetto composto e metodo per fare il medesimo
IT1171290B (it) Microsfere e loro preparazione
DE3677364D1 (de) Markierte makromolekuele; verfahren zu ihrer herstellung und ihre verwendung in immunologischen oder immunocytochemischen testen.
DE3878326D1 (de) Kunstlunge der membranart und verfahren zu ihrer verwendung.
ATA752478A (de) Enttintungspraeparat und verfahren zu seiner verwendung
DE3676667D1 (de) Elektronenstrahlgeraet zum testen der kennwerte von elektronischen vorrichtungen und methode zu seiner benutzung.
PT74481A (de) Substituierte n-(4-indolyl-piperidino-alkyl)-benzimidazolone verfahren zu ihrer herstellung und ihre verwendung als pharma- zeutika
DE3583365D1 (de) Strahlungssonde und verfahren zum gebrauch derselben.
IT1098105B (it) Metodo ed apparato per la distribuzione di elementi di fissaggio
IT1190675B (it) 3-chinuclidinil glicolati leganti di recettori ed elementi raggi gamma,metodo di loro preparazione e metodi di visualizzazione e analisi mediante loro impiego
PT69958A (de) Hypo-beta-lipoproteinamisches diatetikum verfahren zu seiner herstellung und verwendung
IT8122083A1 (it) Nuovi chinossalin-2-il-etenil-chetoni e procedimento per la loro preparazione
PT72832B (de) Substituierte alpha-aminocarbonyl-1-benzyl-3,4-dihidroisochino-line verfahren zu deren herstellung und deren verwendung
IT1189406B (it) Diossazine,loro preparazione e loro impiego come pigmenti
IT1085058B (it) Preparato e metodo per fissare la polvere
IT1094313B (it) Pigmento molibdico inibente la corrosione e procedimento per la sua preparazione
PT83240A (de) Substituierte toluidine verfahren zu ihrer herstellung diese enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaueresekretionshemmer
IT1131086B (it) Metodo e dispositivo per distinguere le gemme
IT8050455A0 (it) Manica filtrante e procedimento per la sua fabbricazione
IT1155363B (it) Telomeri fotoreticolabili e procedimento per il loro ottenimento
IT1136638B (it) Chinuclodinil benzilati leganti di recettori e emettenti raggi gamma,metodi di loro preparazione e metodi di visualizzazione ed analisi mediante loro utilizzazione
IT1115926B (it) Copulanti magenta 5-pirazolonici per uso fotografico elementi fotografici che li contengono e procedimento per la loro produzione
PT80188A (de) Das streptomyceten-plasmid psg5 verfahren zu seiner gewinnung und seiner verwendung
LU80632A1 (de) 3-di-n-propyl-acetoxy-benzodiazepin-2-one und verfahren zu deren herstellung

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970228